Automated Flow Synthesis of Artificial Heme Enzymes for Enantiodivergent Biocatalysis
The remarkable efficiency with which enzymes catalyze small-molecule reactions has driven their widespread application in organic chemistry. Here, we employ automated fast-flow solid-phase synthesis to access catalytically active full-length enzymes without restrictions on the number and structure of noncanonical amino acids incorporated. We demonstrate the total syntheses of iron-dependent <i>Bacillus subtilis</i> myoglobin (BsMb) and sperm whale myoglobin (SwMb). The synthetic enzymes displayed excellent enantioselectivity and yield in carbene transfer reactions. Absolute control over enantioselectivity in styrene cyclopropanation was achieved using synthetic L- and D-BsMb mutants, which delivered each enantiomer of cyclopropane product in identical and opposite enantiomeric enrichment. BsMb mutants outfitted with noncanonical amino acids were used to facilitate detailed structure-activity relationship studies, revealing a previously unrecognized hydrogen-bonding interaction as the primary driver of enantioselectivity in styrene cyclopropanation. We anticipate that our approach will advance biocatalysis by providing reliable and rapid access to fully synthetic enzymes possessing noncanonical amino acids.
Authors
- Andrei Loas (ORCID: https://orcid.org/0000-0001-5640-1645)
- Bradley L. Pentelute (ORCID: https://orcid.org/0000-0002-7242-801X)
- Giulio Fittolani (ORCID: https://orcid.org/0000-0001-6201-3454)
- Stephen L. Buchwald (ORCID: https://orcid.org/0000-0003-3875-4775)
- Dennis A. Kutateladze (ORCID: https://orcid.org/0000-0002-5706-7092)
Institutions
- Broad Institute (US)
- Center for Environmental Health (US)
- Massachusetts Institute of Technology (US)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1021/jacs.4c13832
- Citations
- 4
- Primary Topic
- Innovative Microfluidic and Catalytic Techniques Innovation
- Type
- article
- Field-Weighted Citation Impact
- 2.70
Funders
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institute of General Medical Sciences